JENNIFER DANKEL: Open Payments
NPI 1962605758 · SINKING SPRING, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$290 in 13 payments from 10 companies in 2025. Trend: 2023 $595 · 2024 $470 · 2025 $290
Food & beverage: $290
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 2 | $54 |
| Novartis Pharmaceuticals Corporation | 2 | $46 |
| Janssen Biotech, Inc. | 1 | $43 |
| Galderma Laboratories, L.P. | 2 | $41 |
| PFIZER INC. | 1 | $25 |
| Verrica Pharmaceuticals Inc. | 1 | $19 |
| Organon LLC | 1 | $17 |
| Arcutis Biotherapeutics, Inc. | 1 | $16 |
| ABBVIE INC. | 1 | $15 |
| LEO Pharma Inc. | 1 | $14 |
Products named: DUPIXENT, TREMFYA, NEMLUVIO, CIBINQO, COSENTYX, Rhapsido, YCANTH, VTAMA.
Industry payments across PA — which companies pay providers there.
